Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Runna Ai, Yulin Sun, Zhimin Guo, Wei Wei, Lanping Zhou, Fang Liu, Denver T. Hendricks, Yang Xu & Xiaohang Zhao. (2016) NDRG1 overexpression promotes the progression of esophageal squamous cell carcinoma through modulating Wnt signaling pathway. Cancer Biology & Therapy 17:9, pages 943-954.
Read now
Read now
Wenlei Zhuo, Liang Zhang, Yan Wang, Bo Zhu & Zhengtang Chen. (2012) Cyclin D1 G870A Polymorphism is a Risk Factor for Esophageal Cancer Among Asians. Cancer Investigation 30:9, pages 630-636.
Read now
Read now
Articles from other publishers (25)
Sarika Daripally & Kiranmayi Peddi. (2021) 5-year cumulative survival of oral cancer patients with FAS and FASL SNPs. Meta Gene 27, pages 100826.
Crossref
Crossref
Jie Tian, Caiyang Liu, Guanchu Liu, Chunjian Zuo & Huanwen Chen. (2019) Cumulative evidence for association between genetic polymorphisms and esophageal cancer susceptibility: A review with evidence from meta‐analysis and genome‐wide association studies. Cancer Medicine 8:3, pages 1289-1305.
Crossref
Crossref
Xue Hou, Run-Bin Liang, Jin-Chang Wei, Ying Xu, Jian-Hua Fu, Rong-Zhen Luo, Jie-Hua He, Lan-Jun Zhang, Peng Lin & Hao-Xian Yang. (2016) Cyclin D1 expression predicts postoperative distant metastasis and survival in resectable esophageal squamous cell carcinoma. Oncotarget 7:21, pages 31088-31096.
Crossref
Crossref
Meenakshi Umar, Rohit Upadhyay, Shaleen Kumar, Uday Chand Ghoshal & Balraj Mittal. (2014) Role of novel and GWAS originated PLCE1 genetic variants in susceptibility and prognosis of esophageal cancer patients in northern Indian population. Tumor Biology 35:11, pages 11667-11676.
Crossref
Crossref
Pei-Wen Yang, Min-Shu Hsieh, Ya-Chuan Huang, Ching-Yueh Hsieh, Tzu-Hsuan Chiang & Jang-Ming Lee. (2014) Genetic Variants of EGF and VEGF Predict Prognosis of Patients with Advanced Esophageal Squamous Cell Carcinoma. PLoS ONE 9:6, pages e100326.
Crossref
Crossref
Aysegul Verim, Nazli Ozkan, Saime Turan, Gurbet Korkmaz, Canan Cacina, Ilhan Yaylim & Turgay Isbir. (2013) Association of the Cylin D1 G870A Polymorphism with Laryngeal Cancer: Are they Really Related?. Asian Pacific Journal of Cancer Prevention 14:12, pages 7629-7634.
Crossref
Crossref
Meenakshi Umar, Rohit Upadhyay, Shaleen Kumar, Uday Chand Ghoshal & Balraj Mittal. (2013) Modification of risk, but not survival of esophageal cancer patients by esophageal cancer-related gene 1 Arg290Gln polymorphism: A case-control study and meta-analysis. Journal of Gastroenterology and Hepatology 28:11, pages 1717-1724.
Crossref
Crossref
PIN GUO, JIN LAN, JIANWEI GE, QUANMIN NIE, QING MAO & YONGMING QIU. (2013) miR-708 acts as a tumor suppressor in human glioblastoma cells. Oncology Reports 30:2, pages 870-876.
Crossref
Crossref
Umit Zeybek, Ilhan Yaylim, Nazli Ezgi Ozkan, Gurbet Korkmaz, Saime Turan, Didem Kafadar, Canan Cacina & Ali Metin Kafadar. (2013) Cyclin D1 Gene G870A Variants and Primary Brain Tumors. Asian Pacific Journal of Cancer Prevention 14:7, pages 4101-4106.
Crossref
Crossref
Ying Piao, Zhaozhe Liu, Zhenyu Ding, Long Xu, Fang Guo, Qingqing Sun & Xiaodong Xie. (2013) EGF +61A>G polymorphism and gastrointestinal cancer risk: A HuGE review and meta-analysis. Gene 519:1, pages 26-33.
Crossref
Crossref
Youngjoo Lee, Kyong-Ah Yoon, Jungnam Joo, Donghoon Lee, Kieun Bae, Ji-Youn Han & Jin Soo Lee. (2013) Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study. Carcinogenesis 34:2, pages 307-313.
Crossref
Crossref
YAPING XU, LIMING SHENG & WEIMIN MAO. (2013) Role of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of esophageal carcinoma and the suggested mechanisms of action. Oncology Letters 5:1, pages 19-24.
Crossref
Crossref
Meng Li, Weijian Dai & Huanqin Zhou. (2013) Cyclin D1 G870A Polymorphism and Risk of Nasopharyngeal Carcinoma: A Meta-Analysis. The Scientific World Journal 2013, pages 1-8.
Crossref
Crossref
Delphine Borchiellini, Marie-Christine Etienne-Grimaldi, Juliette Thariat & Gérard Milano. (2012) The impact of pharmacogenetics on radiation therapy outcome in cancer patients. A focus on DNA damage response genes. Cancer Treatment Reviews 38:6, pages 737-759.
Crossref
Crossref
Milena Gusella, Felice Pasini & Giovanni de Manzoni. 2012. Treatment of Esophageal and Hypopharyngeal Squamous Cell Carcinoma. Treatment of Esophageal and Hypopharyngeal Squamous Cell Carcinoma
69
76
.
Jang-Ming Lee, Shi-Yi Yang, Pei-Wen Yang, Chia-Tung Shun, Ming-Tsang Wu, Chih-Hung Hsu, Chia-Chi Lin, Jason Chia-Hsien Cheng, Ying-Hao Wang, Tzu-Hsuen Chuang, Jin-Shing Chen, Hsao-Hsun Hsu, Pei-Ming Huang, Shuenn-Wen Kuo & Yung-Chie Lee. (2011) Polymorphism in Epidermal Growth Factor Receptor Intron 1 Predicts Prognosis of Patients with Esophageal Cancer after Chemoradiation and Surgery. Annals of Surgical Oncology 18:7, pages 2066-2073.
Crossref
Crossref
Showket Hussain, Yuvaraj M.Nisha Thakur, Irfana Salam, Neha Singh, Mohammad Muzaffar Mir, Mohammad Akbar Bhat, Mushtaq A. Siddiqi, Bhudev C. Das & Mausumi Bharadwaj. (2011) Association of cyclin D1 gene polymorphisms with risk of esophageal squamous cell carcinoma in Kashmir Valley—A high risk area. Molecular Carcinogenesis 50:7, pages 487-498.
Crossref
Crossref
Rohit Upadhyay, Rohini Khurana, Shaleen Kumar, Uday Chand Ghoshal & Balraj Mittal. (2010) Role of Survivin Gene Promoter Polymorphism (?31G>C) in Susceptibility and Survival of Esophageal Cancer in Northern India. Annals of Surgical Oncology 18:3, pages 880-887.
Crossref
Crossref
Wei Xu, Yan Li, Xueli Wang, Bo Chen, Shan Liu, Yan Wang, Weihong Zhao & Jianqing Wu. (2009) Association between EGF promoter polymorphisms and cancer risk: a meta-analysis. Medical Oncology 27:4, pages 1389-1397.
Crossref
Crossref
H Takeshita, D Ichikawa, S Komatsu, M Tsujiura, T Kosuga, K Deguchi, H Konishi, R Morimura, A Shiozaki, H Fujiwara, K Okamoto & E Otsuji. (2010) Prediction of CCND1 amplification using plasma DNA as a prognostic marker in oesophageal squamous cell carcinoma. British Journal of Cancer 102:9, pages 1378-1383.
Crossref
Crossref
Yajuan Li, Qing Xie, Fengmin Lu, Jingmin Zhao, Panyong Mao, Zhuo Li, Shuang Liu & Hui Zhuang. (2010) Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients. Liver International 30:1, pages 112-118.
Crossref
Crossref
Lin Cui, Xin-Min Pan, Chun-Fen Ma, Jun Shang-Guan, Hai-Bin Yu, Guang-Xue Chen & Jia Wang. (2009) Association Between Epidermal Growth Factor Polymorphism and Esophageal Squamous Cell Carcinoma Susceptibility. Digestive Diseases and Sciences 55:1, pages 40-45.
Crossref
Crossref
R. A. Mason, E. V. Morlock, M. R. Karagas, K. T. Kelsey, C. J. Marsit, A. R. Schned & A. S. Andrew. (2009) EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis. Carcinogenesis 30:7, pages 1155-1160.
Crossref
Crossref
K Einarsdóttir, H Darabi, K Czene, Y Li, Y L Low, Y Q Li, C Bonnard, S Wedrén, E T Liu, P Hall, J Liu & K Humphreys. (2009) Common genetic variability in ESR1 and EGF in relation to endometrial cancer risk and survival. British Journal of Cancer 100:8, pages 1358-1364.
Crossref
Crossref
Monika Vishnoi, Sachchida Nand Pandey, Dinesh Raj Modi, Ashok Kumar & Balraj Mittal. (2008) Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor ?1 -509C>T gene polymorphisms with gallbladder cancer. Human Immunology 69:6, pages 360-367.
Crossref
Crossref